Newsroom

Sorted by: Latest

-

百奧賽圖與百濟神州達成抗體分子授權合約,加快創新藥物開發

中國北京和美國麻省劍橋--(BUSINESS WIRE)--(美國商業資訊)-- 創新技術驅動新藥研發的國際性生物科技公司百奧賽圖(HKEX:02315)今日宣布與全球腫瘤治療創新公司百濟神州達成抗體分子的全球授權合約。 百濟神州此前已獲得百奧賽圖RenMice®全人抗體平台的使用授權,本次雙方在已建立的良好合作基礎上進一步將合作擴大至抗體分子授權領域,代表雙方合作的持續深化。 百奧賽圖董事長及CEO沈月雷博士表示:「百濟神州是全球藥物開發領域的領軍企業,我們欣然與其達成這一策略性合作。此次授權的多個抗體分子均源自百奧賽圖自主開發的RenMice®全人抗體發現平台,充分展現了我們賦能合作夥伴、加快創新藥物開發的能力。我們期待這些極具潛力的抗體分子能夠早日推進至臨床階段,為全球病患帶來創新治療方案。」 根據協議條款,百濟神州將向百奧賽圖支付首付款。此外,百奧賽圖還將有權獲得開發和監管里程碑付款、商業化里程碑付款,以及基於淨銷售額的權利金。 關於百奧賽圖 百奧賽圖(股票代號:02315.HK)是一家創新技術驅動新藥研發的國際性生物科技公司,致力於成為全球新藥發源地。百奧賽圖以底層基因編輯技...
-

AltynGold Plc UK Regulatory Announcement: H1 2025 operational update

LONDON--(BUSINESS WIRE)--  AltynGold Plc ("AltynGold" or the "Company") H1 2025 Production and Operational update Gold production up 44%, as Sekisovskoye processing achieves targeted run rate London, 18 July 2025 - AltynGold (LSE:ALTN) is pleased to announce its production and operational update for the six months to 30 June 2025 ("H1 2025" or the "Period"). The Period delivered a 44% increase in gold production as it started to gain the full benefit of the processing plant upgrade at its prima...
-

First Trust Portfolios UK Regulatory Announcement: Form 8.3 - NCC Group plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: First Trust Advisors L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be name...
-

Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 17 July 2025 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 17 July 2025 Number of Public Shares Purchased: 45,056 S...
-

SBC Medical Group adquire MB Career Lounge: “JUN CLINIC” integra-se ao grupo, consolidando sua posição competitiva em um mercado em expansão

IRVINE, Califórnia--(BUSINESS WIRE)--A SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” ou a “Empresa”), uma franquia global e fornecedora de serviços para clínicas de estética, divulgou que, em 17 de julho de 2025, efetivou a aquisição da MB career lounge, Co., Ltd. (“MB career lounge”), uma prestadora privada de serviços de suporte administrativo para instituições médicas, especializada em consultoria, treinamento e soluções de recursos humanos no Japão, por meio uma trans...
-

BlackSky Announces Pricing of Upsized $160 Million Convertible Senior Notes Offering

HERNDON, Va.--(BUSINESS WIRE)--BlackSky Technology Inc. (NYSE: BKSY) (“BlackSky”) today announced the pricing of $160 million principal amount of 8.25% Convertible Senior Notes due 2033 (the “notes”) in a private offering (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $125 million aggregate...
-

SBC Medical Group übernimmt MB Career Lounge: „JUN CLINIC” wird Teil der Gruppe und stärkt damit ihre Wettbewerbsposition in einem wachsenden Markt

IRVINE, Kalifornien--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) („SBC Medical” oder das „Unternehmen”), ein globaler Franchisegeber und Dienstleister für ästhetische Kliniken, gab bekannt, dass es am 17. Juli 2025 MB Career Lounge, Co., Ltd. („MB Career Lounge”), einen privaten Anbieter von Management-Support-Dienstleistungen für medizinische Einrichtungen mit Spezialisierung auf Beratung, Schulung und Personalwesen in Japan, im Rahmen einer Aktienkaufvereinbarung ge...
-

SBC Medical Group acquiert MB Career Lounge : « JUN CLINIC » rejoint le groupe, renforçant ainsi sa position concurrentielle sur un marché en pleine croissance

IRVINE, Californie--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq : SBC) (« SBC Medical » ou la « Société »), franchise mondiale et fournisseur de services pour les cliniques esthétiques, a annoncé aujourd’hui avoir acquis, le 17 juillet 2025, MB career lounge, Co., Ltd. (« MB career lounge »), une société privée fournissant des services de soutien à la gestion pour les établissements médicaux, spécialisée dans le conseil, la formation et les solutions en matière de ressource...
-

Weave Announces Date of Second Quarter 2025 Financial Results and Conference Call

LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the second quarter 2025 after U.S. markets close on Thursday, July 31, 2025. Company management will host a conference call and webcast at 4:30 p.m. ET to discuss Weave’s financial results and provide a business update. Individuals interested in listening to the confere...
-

Samenvatting: SBC Medical Group neemt MB Career Lounge over: 'JUN CLINIC' voegt zich bij de groep en versterkt de concurrentiepositie in een groeiende markt

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical' of het 'bedrijf'), een wereldwijde franchise en aanbieder van diensten voor esthetische klinieken, heeft aangekondigd dat het op 17 juli 2025 MB Career Lounge, Co., Ltd. ('MB Career Lounge') heeft overgenomen. MB Career Lounge, een particuliere leverancier van managementondersteunende diensten voor medische instellingen, gespecialiseerd in consultancy, training en HR-oplossingen in Japan, is ve...